Navigation Links
Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds
Date:7/15/2010

By Amanda Gardner
HealthDay Reporter

WEDNESDAY, July 14 (HealthDay News) -- The controversial diabetes drug Avandia does raise the risk of heart attack more than other medications of its kind but should stay on the market with tightened controls, a U.S. government advisory panel recommended late Wednesday.

By a complex series of votes, the 33-member panel of experts rejected the option that the U.S. Food and Drug Administration remove Avandia from the market for safety reasons.

The series of votes started, according to the New York Times, with 18 members of the panel voting that Avandia might up the risk of heart attack, six saying they weren't concerned about a raised risk, and nine saying they were unsure.

On their second vote, however, only one member of the committee thought that Avandia increases the risk of death when compared with older medicines, 20 said it did not increase the risk of death, and 12 remained unsure.

The panel seemed more decided when comparing Avandia's safety risks to its sister medication, Actos. Twenty panel members voted that Avandia was more likely to cause heart attack than Actos, four voted that it was no more likely to do so, and eight said they didn't know, the Associated Press reported.

And on the key vote, the decision on Avandia's future, 12 members voted for pulling the drug, 17 voted for new warning label revisions or restrictions on use, and three voted that no changes were needed.

"I don't think there's any question that the use of the drug will decrease and that both physicians and patients will look at the warning very carefully before prescribing Avandia, although that assumes that the final FDA ruling will follow the panel's recommendation," said Dr. Alan Kadish, president and CEO of Touro College, after the votes.

The outcome, he added, was not a surprise. "I expected the vote to be split, and it was split in even more comp
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. FDA Panel Seems Skeptical Over Key Avandia Data
2. FDA Panel Appears Skeptical Over Key Avandia Data
3. Avandia Heart Risks Buried by Drug Company: Report
4. FDA Reviewer Questions Results of Key Avandia Trial
5. Latest Study on Diabetes Drug Avandia Finds No Heart Risks
6. Diabetes Drug Avandia Ups Heart Risk, Reviews Conclude
7. Maher Law Firm Warns Avandia Users - NY Times Reports - FDA Recommends Recall of Avandia
8. FDA: No Decision on Whether to Pull Diabetes Drug Avandia Off the Market
9. FDA Says It Hasnt Decided Whether to Pull Diabetes Drug Avandia Off the Market
10. Remove Diabetes Drug Avandia From Market: FDA Documents
11. Remove Diabetes Drug Avandia From Market: FDA Reports
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds
(Date:8/20/2014)... WEDNESDAY, Aug. 20, 2014 (HealthDay News) -- Pigs, hearts ... which is twice as long as previously achieved, researchers ... find ways to use animal organs to shorten transplant ... from genetically engineered piglets into baboons, abdomens. The genetic ... system response are what enabled the hearts to survive ...
(Date:8/20/2014)... WEDNESDAY, Aug. 20, 2014 (HealthDay News) -- Loss of ... help explain why many seniors have trouble falling and ... patients, sleep disruption can be especially severe and often ... researchers. The investigators analyzed data from the Rush ... who enrolled at age 65 and are being followed ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. ... cells grow may help doctors diagnose and treat the most ... have found that the deadliest skin cancers occur most often ... long history of sun exposure. These lesions also grow ... cell growth -- called "high mitotic rate" -- is ...
(Date:8/20/2014)... The Board of Directors of top ... is pleased to announce the expansion of its ... and the surrounding region. In support of this ... AIA has relocated to the firm’s office in Shanghai, ... and design and to better support regional clients. ...
(Date:8/20/2014)... Tuberculosis is one of the most persistent and deadliest ... million people each year. , Scientists who study tuberculosis ... tuberculosis likely spread from humans in Africa to seals ... America and transmitted it to Native people there before ... Mycobacterial Genomes Reveal Seals as a Source of New ...
Breaking Medicine News(10 mins):Health News:Pigs' Hearts Beat for a Year in Baboons' Abdomens 2Health News:Seniors' Sleep Woes May Be Linked to Loss of Brain Cells 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 3Health News:Perkins Eastman Expands Presence in China 2Health News:Perkins Eastman Expands Presence in China 3Health News:New research shows seals and sea lions likely spread tuberculosis to humans 2Health News:New research shows seals and sea lions likely spread tuberculosis to humans 3
... scientists have found that a deficiency in a key tumor suppressor ... adult brain cancer. The study, conducted in mice that mimic human ... way to screen for the disease early. Appearing June 2 ... show for the first time that:, Glioblastoma, the type of ...
... Clinic researchers have demonstrated that a noninvasive screening test can ... above the colon -- including pancreas, stomach, biliary and esophageal ... studies being presented at Digestive Disease Week 2009 in Chicago, ... account for approximately one in four cancer deaths. While high ...
... at regulatory and clinical concerns with generic immunosuppression medications ... advisory by the International Society for Heart and Lung ... Journal of Heart and Lung Transplantation ( ... Thoracic transplant patients require immunosuppressant medications ...
... from prolonged flexing of the elbow, experts say , ... Then, Guitar Hero wrist. Now, for the latest affliction of ... as cubital tunnel syndrome, cell phone elbow is numbness, tingling ... of the ulnar nerve, which passes along the bony bump ...
... , First hospital in Georgia to use a ... improve patient care and outcomes. , , WOBURN, ... Memorial University Medical Center in Savannah, Georgia has ... to 3 days earlier than conventional methods to help their ...
... initiate phase II trial in hepatic encephalopathy - , ... Inc. today announced top-line results from a phase I study ... presented as part of the 2009 Digestive Disease Week meeting. ... a Novel Ammonia-Reducing Agent in Healthy Adults and Patients with ...
Cached Medicine News:Health News:Most common brain cancer may start in neural stem cells 2Health News:Most common brain cancer may start in neural stem cells 3Health News:Most common brain cancer may start in neural stem cells 4Health News:Improved DNA stool test could detect digestive cancers in multiple organs 2Health News:Improved DNA stool test could detect digestive cancers in multiple organs 3Health News:More stringent evaluation on the use of generic medications in thoracic transplantation 2Health News:'Cell Phone Elbow' -- A New Ill for the Wired Age 2Health News:'Cell Phone Elbow' -- A New Ill for the Wired Age 3Health News:Memorial University Medical Center (MUMC) Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections 2Health News:Memorial University Medical Center (MUMC) Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections 3Health News:Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis 2Health News:Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis 3Health News:Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis 4
(Date:8/20/2014)... Aug. 20, 2014 Torrance Memorial Medical ... advanced, ventilator technology from Covidien to provide a ... patients. The acute care ventilator is ... to conventional mechanical ventilation, and help clinicians move ... Patients on mechanical ventilation are often sedated to ...
(Date:8/20/2014)... Aug. 20, 2014 The National Necrotizing Fasciitis Foundation ... has been successfully treated for a life threatening form ... Anibal R. Gauto , Medical Director of Inpatient Wound Care ... Center in Rancho Mirage, California . ... Dr. John Crew at Seton Hospital in ...
(Date:8/20/2014)... 20, 2014 Research and Markets ... "Global Advanced Wound Care and Closure Market (Types, ... Global Trends, Company Profiles, Demand, Insights, Analysis, Research, ... report to their offering. ... and closure market (types, applications, end user and ...
Breaking Medicine Technology:Torrance Memorial Medical Center Acquires Advanced Ventilator Technology to Enhance Patient Care 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 3Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 4Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 5Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 6Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2
... A new study lead by James M. ... School of,Medicine and presented by Charles Simone II, ... that when it comes to seeking,information on the ... from English-speaking patients with regards to,both frequency of ...
... 31 A recent outbreak of MRSA,(Methicillin- resistant ... should cause organizations and facilities nationwide to,reevaluate and ... is resistant to common antibiotics. It manifests its,symptoms ... other pus-filled,lesions. Superbug infections prior to 2007 were ...
Cached Medicine Technology:University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites 2University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites 3'Superbug' Outbreak Calls for Immediate Increased Attention on Infection Control 2
For the rapid determination of human chorionic gonadotropin (hCG) in urine and serum. The test strip is used to obtain a visual qualitative result....
... GE Healthcares new Vivid ... miniaturized cardiovascular ultrasound system to provide high-performance, ... , Vivid i addresses ... care access to complete, real-time diagnostic ...
... The Bio-Quant, Inc. CRP test is ... vitro test. It is designed for ... (CRP) in human serum or whole ... concentration in serum or whole blood ...
The Bio-Quant CK-MB test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of,CK-MB in human serum specimens as an aid in the diagnosis of myocar...
Medicine Products: